Continuous intracranial administration of suberoylanilide hydroxamic acid (SAHA) inhibits tumor growth in an orthotopic glioma model (Q40169260)
Jump to navigation
Jump to search
scientific article published on 20 February 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Continuous intracranial administration of suberoylanilide hydroxamic acid (SAHA) inhibits tumor growth in an orthotopic glioma model |
scientific article published on 20 February 2007 |
Statements
1 reference
Continuous intracranial administration of suberoylanilide hydroxamic acid (SAHA) inhibits tumor growth in an orthotopic glioma model (English)
1 reference
Hasan C Ugur
1 reference
Naren Ramakrishna
1 reference
Lorenzo Bello
1 reference
Lata G Menon
1 reference
Seung-Ki Kim
1 reference
Peter M Black
1 reference
Rona S Carroll
1 reference
20 February 2007
1 reference
1 reference
83
1 reference
3
1 reference
267-275
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference